Sun Pharma elevates Aalok Shanghvi as COO

Sun Pharma, India's largest drugmaker, has designated Aalok Shanghvi as Chief Operating Officer. Aalok, the son of promoter Dilip Shanghvi, has held various strategic roles since joining in 2006 and has been a whole-time director since June 2023. Sun Pharma reported revenue of ₹48,496 crore for FY24, with a market valuation of ₹4.17 lakh crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hUaILYN
via IFTTT